Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns.

Transfusion - 1 Jan 2007

Castro Vagner, Kroll Hartmut, Origa Andréa F, Falconi Mônica A, Marques Sílvia B D, Marba Sérgio T, Passini Renato, Annichino-Bizzacchi Joyce M, Costa Fernando F, Santoso Sentot, Arruda Valder R

Abstract excerpt

BACKGROUND: Neonatal thrombocytopenia (NT) occurs in 0.5 to 0.9% of unselected Caucasian newborns. However, the prevalence of this complication in other populations is unknown. In this study the prevalence/causes of NT was determined in Brazilian newborns, a population characterized by admixture...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Antigens, Human Platelet

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Platelets

Share to HLA Antigens

Share to Isoantibodies

Share to Mothers

Share to Platelet Count

Share to Thrombocytopenia

Source

Identifiers

PMID: 17207231
DOI: 10.1111/j.1537-2995.2007.01064.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17207231-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns.PMID 17207231Read ↗

Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.Semantic proximity Read ↗

Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and managementSemantic proximity Read ↗

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn.Semantic proximity Read ↗

Antenatal management of fetal and neonatal alloimmune thrombocytopenia: Integration of clinical history and maternal HLA-DRB3*01:01 genotyping in clinical decision-making.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies.Semantic proximity Read ↗

Frequency distribution of antigens in the human platelet antigen-1 system in the western Indian population.Semantic proximity Read ↗

Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial.Semantic proximity Read ↗

Fetoneonatal alloimmune thrombocytopenia (FNAIT): our experience.Semantic proximity Read ↗

Assessment of human platelet antigen (HPA)-1a alloimmunisation in women identified at increased risk for foetal and neonatal alloimmune thrombocytopaenia (FNAIT): a prospective, natural history studySemantic proximity Read ↗

[Laboratory Diagnosis and Clinical Data Analysis of Neonatal Alloimmune Thrombocytopenia Caused by Anti-HLA Antibodies in Nanning].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.